MedLink International, Inc (MLKNA) Fair Value & Analysis
Healthcare · US · Market cap $4.8K
MedLink International, Inc
MLKNA · US
Fair value as of: Jun 26, 2026
From 15 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.2200 to $0.0001 (−100.0%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0001 – $0.0001 · the $0.0001 price screens below the $0.0001 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
MedLink International, Inc (MLKNA) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 43/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, MedLink International, Inc generated revenue of $6.0M at a net margin of 3.4%. It earns a return on equity of 9.4%. The stock trades on a trailing P/E of 0.0. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
MedLink International, Inc. engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data. The company offers MedLink iSuite EHR that automates physician activities, such as prescribing, dictating, ordering lab tests and viewing results, documenting clinical encounters, and capturing charges, among others; and MedLink IX (Information eXchange), an enterprise connectivity solution that links providers and healthcare services to achieve interoperability deployed in commercial and hospital laboratories. It also provides MedLink Lab, a Web browser based lab ordering and results portal hosted on the company's virtual cloud platform; and MedLink Connect, which allows laboratory services to utilize MedLink IX to deliver laboratory results to multiple HIS and EMR, as well as Health Information networks. MedLink International sells its products …
Revenue & earnings trend
FY2000 – FY2010 · reported fiscal years
MedLink International, Inc reported revenue of $6.0M in FY2010 versus $12.0K in FY2006, a compound +372.8%/yr. Reported net income was $203K in FY2010, compounding +7.8%/yr from FY2000.
Is MLKNA fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$96.00 | R$25.67 | -73% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is MedLink International, Inc (MLKNA) undervalued?
What is the fair value of MLKNA?
What is the quality score of MLKNA?
What is the revenue of MedLink International, Inc (MLKNA)?
What is the net profit margin of MLKNA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.